T h e 20 known transforming one genes of retroviruses are defined by sequences which are transduced from cellular genes, termed proto -one genes. Based on these sequences, viral one genes have been postulated to be transduced cellular cancer genes and proto-owc genes have been postulated to be latent cancer genes that can be activated from within the cell, to cause virus negative tumours. The hypothesis is popular because it promises direct access to cellular cancer genes. However the existence of latent cancer genes presents a paradox since such genes would be most undesirable for eukaryotes. The hypothesis predicts (i) that viral one genes and proto -one genes are isogenic, (ii) that expression of proto-owc genes induces tumours, (iii) that activated proto -one genes transform diploid cells upon transfection, like viral one genes, and (iv) it predicts diploid tumours. As yet, none of these predictions is confirmed. Instead: (i) Structural comparisons between viral one genes, essential retroviral genes, and the proto -one genes show that all viral on e genes are indeed new genes, rather than transduced cellular cancer genes. They are genetic hybrids put together from truncated viral and truncated proto -one genes, (ii) Proto-<OTC genes are frequently expressed in normal cells, (iii) To date, not one activated proto -one gene has been isolated that transforms diploid cells, (iv) Above all, no diploid tumours with activated protoone genes have been found. Moreover the probability of spontaneous transformation in vivo is at least 109 times lower than predicted from the mechanisms thought to activate proto-one genes. Therefore the hypothesis, that proto -one genes are latent cellular oncogenes, appears to be an over interpretation of sequence homology to structural and functional homology with viral on e genes. Here is is proposed that only rare truncations and recombinations, that alter the germline configuration of cellular genes, generate viral and possibly cellular cancer genes. The clonal chromosome abnormalities that are consistently found in tumour cells are microscopic evidence for rearrangements that may generate cancer genes. The clonality indicates that the tumours are initiated with, and possibly by these abnormalities as predicted by Boveri in 1914.
INTRODUCTION
In order to understand cancer, it is necessary to identify cancer genes. T h e search for such genes and for mechanisms that generate such genes must take into consideration that at the cellular level cancer is a very rare event. T h e kind of cellular transformation that leads to monoclonal tumours in vivo occurs only in about 1 out of 2 x 1017 mitoses in humans or animals. T h e basis for this estimate is that most animal and human tumours are monoclonal (Wolman, 1983; Rowley, 1984; T ren t, 1984; Duesberg, 1987) and that humans and corresponding animals represent about 1016 mitoses (assuming 1014 cells, that go through an average 102 mitoses) and that about 1 in 5 persons die from tumours (Silverberg & Lubera, 1986) .
As yet the only proven cancer genes are the transforming one genes of retroviruses.
T h ese are autonomous transforming genes that are sufficient for carcinogenesis (Duesberg, 1983 (Duesberg, , 1985 . T hu s, these viruses are by far the most direct and efficient natural carcinogens. They transform susceptible cells in culture with the same kinetics as they infect them, and they cause tumours in animals with single-hit kinetics (Duesberg, 1983 (Duesberg, , 1985 . Therefore these viruses are never associated with healthy animals.
However, tumours with retroviruses that contain otic genes are very rare in nature, as only less than 50 cases are recorded from which such viruses were isolated (Duesberg, 1987 (Duesberg, , 1983 (Duesberg, , 1985 'RN A Tum or Viruses' 1985) . Moreover these viruses never have been reported to cause epidemics of cancer. T h e probable reasons are that viral one genes arise naturally only with great difficulty via two illegitimate recombinations, and that once arisen they are very unstable because they are not essential for virus replication (Duesberg, 1983 (Duesberg, , 1985 . Nonessential genes are readily lost due to spontaneous deletion or mutation. Indeed, one genes were originally discovered by analysis of spontaneous deletions of the sre gene, the one gene of Rous sarcoma virus (R S V ) (Duesberg & Vogt, 1970; Martin & Duesberg, 1972) .
Subsequently, about 20 other viral one genes were identified in retroviruses (Duesberg, 1983 (Duesberg, , 1985 Weis et al. 1985 Weis et al. , 1982 . All of these viral one genes were originally defined by 'transformation-specific' sequences that are different from the known sequences of essential virus genes (Duesberg, 1979) .
Since one genes are unstable, they must also be recent additions to retroviruses.
Indeed, the cellular genes from which the transformation-specific sequences on oncogenic retroviruses were transduced have been identified in normal cells. T h is was initially done by liquid hybridization of transformation-specific viral sequences with cellular D N A (Scolnick et al. 1973; Scolnick & Parks, 1974; Tsuchida et al. 1974; Frankel & Fischinger, 1976; Stehelin et al. 1976) , and later by comparing cloned viral one and corresponding cellular genes (Watson et a l. 1983 ). T h e cellular genes from which viral one sequences are derived have since been termed proto -one genes (Duesberg, 1983) .
T h e cellular origin of the transformation-specific sequences of retroviral one genes is frequently presented as a particular surprise ('RNA Tum or Viruses' 1985 Viruses' , 1982 .
However, cells are the only known source of genetic material from which viruses could transduce genetic information and viral transduction is canonical knowledge ever since phage lambda was first shown to transduce beta-galactosidase in the 1950s.
Indeed virsues are themselves derivatives of cellular genes that have evolved away from their progenitor genes as they acquired their capacity of self-replication.
THE HYPOTHESIS THAT PROTO-ONC GENES ARE LATENT CANCER GENES
On the basis of the sequence homology between viral one genes and proto -one genes, viral one genes have been postulated to be transduced cellular cancer genes, and proto -one genes have been postulated to be latent cancer genes (Bishop et al. 1979 (Bishop et al. , K aressei al. 1979 Wang et al. 1979; Bishop, 1981; K lein, 1981; Bishop et al. 1982; Bishop, 1983; Varmus & Bishop, 1986 , Weiss, 1986 . According to this view, termed the oncogene concept (Weiss, 1986) , proto-owc genes are not only converted to transforming genes from without by transducing viruses, but also from within the cell by increased dosage or increased function (Bishop et al. 1979; K aressei al. 1979; Wang et al. 1979; Bishop, 1981; K lein, 1981; Bishop et al. 1982; Bishop, 1983; Varmus & Bishop, 1986; Weiss, 1986) . Activation of latent oncogenes from within the cell is postulated to follow one of four prominent pathways: (i) point mutation (Tabin et al. 1982; Reddy et al. 1982; Taparowsky et al. 1982) ; (ii) chromosomal translocation that brings the latent oncogene under the control of a heterologous enhancer or promoter (K lein, 1981; Leder et al. 1983 ); (iii) gene amplification (Varmus & Bishop, 1986; Weiss, 1986) ; and (iv) activation from a retroviral promoter integrated adjacent to the latent oncogene (Bishop, 1981; K lein, 1981; Bishop et al. 1982; Bishop, 1983; 'RN A Tum or Viruses' 1985; Varmus & Bishop, 1986; Weiss, 1986) . T h u s, this view predicts the latent cancer genes preexist in normal cells. However the existence of latent cancer genes is a paradox, because such genes would obviously be most undesirable for eukaryotes.
Indeed, the oncogene concept was a revision of Huebner's oncogene hypothesis, which postulated activation of latent oncogenic viruses instead of latent cellular oncogenes as causes of cancer (Huebner & Todaro, 1969) . Nevertheless H uebner's hypothesis remained unconfirmed because most human and animal tumours are virus-negative ('RNA Tum or Viruses' 1982 Viruses' , 1985 . Moreover, the retroviruses and D N A viruses that have been isolated from tumours are not directly oncogenic (Duesberg, 1987) , except for the less than 50 isolates of animal retroviruses which contain one genes (Duesberg, 1985; 'RN A Tum or Viruses' 1982 .
T h e revised oncogene hypothesis was at first sight highly attractive because it derived credibility from the proven oncogenic function of retroviral one genes, the viral derivatives of proto -one genes, and because it promised direct access to the long sought cellular cancer genes in virus-free tumours with previously defined viral one genes as hybridization probes. Predictably the hypothesis has focused the search for cellular cancer genes from the 106 genes of eukaryotic cells to the 20 known proto -one genes (Duesberg, 1 9 8 5 ;'RNA Tum or Viruses' 1985; Klein, 1981; Bishop et al. 1982; Bishop, 1983; Varmus & Bishop, 1986; Weiss, 1986) .
T h e hypothesis makes four testable predictions, namely, (i) that viral one genes and proto -one genes are isogenic; (ii) that expression of proto -one genes would cause cancer; (iii) that proto-one genes from tumours would transform diploid cells as do proviral DN A s of viral one genes; and above all (iv) that diploid tumours exist, that differ from normal cells only in activated proto -one genes. Despite record efforts in the last six years, none of these predictions is confirmed. Instead: (i) Genetic and biochemical analyses, that have defined essential retroviral genes, viral one genes and proto -one genes during the last sixteen years, show that viral one genes and proto-one genes are not isogenic (Duesberg, 1983 (Duesberg, , 1985 ) (see below), (ii) Further, it turned out that most proto -one genes are frequently expressed in normal cells (Duesberg, 1985) . (iii) Contrary to expectation, none of the 20 known proto -one genes isolated from tumours functions as a transforming gene when introduced into diploid cells. T h e apparent exceptions of proto-ras and proto-mvc are discussed below. By comparison, proviral DN As of retroviral one genes transform normal cells exactly like the corresponding viruses ('RNA Tum or Viruses' 1982 Viruses' , 1985 . (iv) As yet, no diploid tumours with activated proto -one genes have been found, except for those caused by viruses with one genes (Pitot, 1978; Klein et al. 1980) . Instead of activated oncogenes Duesberg, 1983) , clonal chromosome abnormalities are a consistent feature of virus negative tumours (Wolman, 1983; Rowley, 1984; Trent, 1984; Levan, 1956 ) and also of all those tumours that are infected by retroviruses without one genes (Duesberg, 1987) .
THE CLAIM THAT PROTO-RAS GENES BECOME CANCER GENES DUE TO POINT MUTATIONS
Proto-ras is the cellular precursor of Harvey, Balb and Rasheed murine sarcoma viruses ('RN A Tum or Viruses' 1982 Viruses' , 1985 . Both proto-ras and the viruses encode a colinear protein, termed p21, of 189 amino acids (Fig. 1) . In 1982 it was discovered that proto -ras extracted from a human bladder carcinoma cell line, but not from normal cells, would transform the morphology of a few aneuploid murine cell lines, in particular the 3 T 3 mouse cell line (Tabin et al. 1982; Reddy et al. 1982; Taparowsky et al. 1982) . Subsequently proto-ras DNAs from some other cell lines and rarely from primary tumours (Duesberg, 1985; Feinberg et al. 1983; Fujita et al. 1985; M ilici et al. 1986 ) were also found to transform 3T 3 cells. Since proto-ras behaves like a dominant and autonomous transforming gene in this morphological assay, it was claimed to be a cellular cancer gene (Tabin et al. 1982; Reddy et al. 1982; Taparowsky et al. 1982) . T h e 3 T 3 cell transforming function of the proto-ras gene from the bladder carcinoma was reduced to a single point mutation that changed the 12th ras codon of p21 from the normal gly to val (Tabin et al. 1982; Reddy et al. 1982; Taparowsky et al. 1982) . In the meantime, over 50 different point mutations in five different ras codons have been identified that all activate 3T 3 cell transforming function (Cichutek & Duesberg, 1986; Lowy & Willumsen, 1986) . Since the viral ras genes and proto-ras genes encode the same p21 proteins, whereas most other viral one genes encode proteins that are different from those encoded by proto -one genes ( Fig . 1 ; Duesberg, 1983 Duesberg, , 1985 , this system has been considered a direct support for the hypothesis that viral one genes and proto-one genes are indeed isogenic and hence can become functionally equivalent by point mutations (Bishop, 1983; Varmus & Bishop 1986; Weiss, 1986; Tabin et al. 1982; Reddy et al. 1982; Taparowsky et al. 1982; Lowy & Williumsen, 1986) .
However the following arguments cast doubt on the claims that point mutations are indeed necessary or sufficient to convert proto-ras-to a dominant cancer gene: (1) T h e claim that point mutations convert proto-ras to dominant cancer genes is significantly weakened by the very rare occurrence of ras mutations in the kind of spontaneous tumours in which they are occasionally found (Duesberg, 1985; Feinberg et al. 1983; Fujita et al. 1985; Milici et al. 1986 ). In fact, the gly to v al mutation that was originally found in the human bladder carcinoma cell line (Tabin et al. 1982; Reddy et al. 1982; Taparowsky et al. 1982) , has never been found in a primary tumour. Further, the origin of this mutation may not have coincided with the origin of the tumour, since the mutation was not found in the original tumour but only in a cell line, 10 years after this line was derived from the original bladder carcinoma (Hastings & Franks, 1981) .
On the basis of a numerical argument it is also unlikely that point mutations are sufficient to convert proto-ras genes to dominant cancer genes. T h e frequency of point mutations of eukaryotes is 1 in 108 nucleotides per mitosis (Wabl et al. 1984) . T h u s 50 out of 108 mitoses are expected to generate mutant Harvey ras genes with dominant transforming function. By contrast, spontaneous transformation that leads to clonal tumours only occurs in less than 1 out of about 2 X 1 0 17 mitoses and only a small minority of these contains mutant ras genes.
It may be argued however that indeed 50 out of 108 mitoses generate tumour cells with activated proto-ras and that the immune system eliminates these cells. However this is unlikely, since a point mutation is not an easy target for immunity. Further, animals or humans that are tolerant to ras point mutations would be expected to develop tumours at a very early age, if point mutated proto-ras genes were dominant cancer genes, as the 3 T 3 assay suggests. Instead spontaneous human tumours with activated proto-ras are very rare and all were observed in adults (Rowley, 1984; Feinberg et al. 1983; Fujita et al. 1985; Milici et al. 1986 ).
Moreover the argument that cellular oncogenes exist that can be activated by point mutation and then controlled by immunity is hard to reconcile with the existence of athymic or nude mice which do not develop more spontaneous tumours than other laboratory mice (Sharkey & Fogh, 1984) . Finally, one would predict that in the absence of immunity, as in cell culture, 50 out of 108 normal cells should spontaneously transform due to point mutation of Harvey proto-ras and probably the same number due to mutation of Kirsten proto-ras ('RNA Tum or Viruses' 1985) . Yet spontaneous transformation of cells in culture is clearly a much less frequent event.
In an effort to directly test the hypothesis that ras genes are activated to dominant cancer genes by point mutation, we have analysed whether the transforming function of ras genes does indeed depend on point mutations. Using site-directed mutagen esis, we have found that point mutations are not necessary for transforming function of viral ras genes and proto-ras genes that had been truncated to be structurally equivalent to viral ras genes (Cichutek & Duesberg, 1986) . (2) Contrary to expectation, the same proto-ras DNAs from human tumours that transform aneuploid 3 T 3 cells do not transform diploid human (Sager et al. 1983) or diploid rodent cells (Land et al. 1983; Newbold & Overell, 1983) , the starting material of natural tumours. Thus transformation of 3T 3 cells does not appear to be a genuine assay for transforming genes of diploid cells. Instead of initiating transform ation, mutated proto-ras may just alter the morphology and enhance tumorigenicity of aneuploid 3 T 3 cells. It is consistent with this view that untreated 3 T 3 cells are tumorigenic in nude mice (Boone, 1975; Littlefield, 1982; G reig et al. 1985 ). T hu s, proto-ras genes with point mutations are not sufficient for transformation. They only appear as dominant cancer genes in certain aneuploid cells like the 3T 3 cells.
Assuming that mutated proto-ras genes are cancer genes, like viral one genes, one would expect diploid tumours that differ from normal cells only in ras point mutation. Contrary to expectation, chromosome abnormalities are consistently found in those tumours in which proto-ras mutations are occasionally found (Wolman, 1983; T ren t, 1984) . T h e human bladder carcinoma cell line, in which the first proto-ras mutation was identified, is a convincing example. T h is cell line contains over 80 chromosomes instead of 46 and it includes rearranged marker chromosomes (Hastings & Franks, 1981) . In view of such fundamental chromosome alterations, a point mutation seems to be a rather minor event. T h u s, proto-ras genes with point mutations are neither sufficient nor proven to be necessary for carcinogenesis and are not autonomous cancer genes like viral ras genes. In addition there is no kinetic evidence that the origin of the mutation coincides with the origin of the tumours in which it is found. It is consistent with this view that proto -ras mutations, that register in the 3T 3 cell transformation assay, have been observed to occur in vivo in benign hyperplasias, as for example in benign murine hepatomas (Reynolds et al. 1986 ) or benign purely diploid mouse skin papillomas that differentiate into normal skin cells (Balmain et al. 1984 (Balmain et al. , 1983 Balmain, 1985; K lein & Klein, 1984; Burns et al. 1978) . R as mutations have also been observed to arise after carcinogenesis in aneuploid cancer cells (Albino et al. 1984; Tainsky et al. 1984; Vousden et al. 1984) , rather than to coincide with the origin of cancer. By contrast, viral ras genes are sufficient for transformation and thus initiate transformation of diploid cells in vitro and in vivo with single hit kinetics and concurrent with infection (Duesberg, 1985; Aaronson & Weaver, 1971; HoelzerPierce & Aaronson, 1982) .
T h is then raises the question why viral ras genes are obligatory carcinogens under conditions where proto-ras genes with point mutations are not. Unexpectedly a sequence comparison between proto-ras genes and the known viral ras genes has recently revealed a proto-ras-specific exon, that was not transduced by any of the known retroviruses with ras genes (Cichutek & Duesberg, 1986) . It is as yet unclear whether the untransduced exon has a regulatory or a coding function (Cichutek & Duesberg, 1986) . It follows however that proto-ras and viral ras genes are not isogenic (F ig . 1). Since four different viral ras genes have been shown to lack the same proto-ras exon, and since point mutations are not necessary for transforming function, we have proposed that proto-ras genes derive transforming function for diploid cells by truncation of an upstream exon and recombination with a retroviral promoter (Cichutek & Duesberg, 1986 ) (see below).
THE CLAIM THAT THE PROTO-MTC GENE BECOMES A CANCER GENE UNDER THE INFLUENCE OF A HETEROLOGOUS CELLULAR ENHANCER
Proto-mye is the cellular precursor of four avian carcinoma viruses termed M C29, M H 2, C M II and OKIO with directly oncogenic mye genes (Duesberg, 1985) . T h e transforming host range of viral myc genes appears to be limited to avian cells, as murine cells are not transformed by cloned proviral DNAs (Land et al. 1983; Rapp et al. 1985) . Nevertheless, it is thought that proto-mvc, brought under the control of heterologous cellular enhancers or promoters by chromosome translocation, is the cause of human Burkitt's lymphoma or mouse plasmacytoma (Leder et al. 1983; Klein & K lein, 1984; Adams et al. 1985) .
T h e following arguments cast doubt on whether such activated proto-wyc genes are indeed necessary or sufficient for carcinogenesis:
(1) T h e human proto-myc gene is located on chromosome 8. T h is chromosome is typically rearranged in B-cell lines derived from Burkitt's lymphomas (Duesberg, 1985; Leder et al. 1983; K lein, 1985) . However, although chromosome 8 is subjected to translocations, proto-wryc is frequently not translocated and when translocated it is frequently not rearranged (Duesberg, 1985; Leder et al. 1983; K lein & K lein, 1984) .
Moreover no rearrangements of chromosome 8 were observed in about 5 0 % of primary Burkitt's lymphomas; instead other chromosome abnormalities were recorded (Biggar et al. 1981) . T h u s, proto-wyc translocation is not necessary for lymphomagenesis.
(2) Expression of proto-myc is not consistently enhanced in lymphomas (D ues berg, 1985) .
(3) As yet no proto -myc gene isolated from a tumour has been demonstrated to transform any cells (Duesberg, 1985) . In an effort to assay transforming function in v iv o , a proto -myc gene, that was artificially linked to heterologous enhancers, was introduced into the germ line of mice (Adams et al. 1985) . Several of these transgenic mice developed lymphomas after 1 to 5 months, implying that activated proto-myc had transformed diploid cells. However the lymphomas of the transgenic mice were all monoclonal (Adams et al. 1985 ). T hu s, if the activated proto-myc gene was indeed responsible for the lymphomas, it would be an extremely inefficient carcinogen, because only 1 of about 108 'control' B-cells of the same mouse with the same transgenic m yc gene was transformed. Moreover, there is no deletion or mutation analysis to show that the activated proto-»z>'C played a direct role in the tumours of the transgenic mice (Adams et al. 1985) . By contrast, viral myc genes transform all susceptible cells directly and inevitably (Duesberg, 1985) . (4) If translocated proto-myc were the cause of Burkitt's lymphomas, one would expect all tumours to be diploid and to carry only 2 abnormal chromosomes, namely, number 8 and the chromosome that was subject to reciprocal translocation with number 8. However, as mentioned above, primary Burkitt's lymphomas exist with two normal chromosomes 8 but with other chromosome abnormalities (Biggar et al. 1981 ). T h u s, translocated proto-wryc genes are not sufficient nor proven to be necessary for carcinogenesis.
THE PROBABILITY OF SPONTANEOUS TRANSFORMATION IN VIVO IS AT LEAST 109 TIMES LOWER THAN PREDICTED FROM PROTO-OiVC GENE ACTIVATION
It was estimated above that the probability of spontaneous transformation that leads to monoclonal tumours in humans is 2 x l 0 -1/ per mitosis. By contrast, one would expect activation of a preexisting, latent proto -one gene to be a much more frequent event. For a given proto -one gene, the probability of activation per mitosis would be the sum of the probabilities associated with each of the four putative pathways (Varmus & Bishop, 1986; Weiss, 1986 ) of proto -one activation: (1) T h e probability of a point mutation per nucleotide per mitosis is about 1 in 108 (Wabl et al. 1984) (and thus about 50 in 108 for Harvey proto-ras). T h e probability that any one of the 20 known proto -one genes is activated would be 2 x 10" '.
(2) T h e probability of a given proto -one gene to be activated by amplification is about 1 in 10s, considering that about 1 in 103 to 103 mitoses leads to gene amplification in vitro and possibly in vivo and that about 103 out of the 106 kilobases (kb) of eukaryotic D N A are amplified (Stark, 1986; Schimke et al. 1986 ). T h e probability that any one of the 20 known proto -one genes would be activated by amplification would then be 2X 10~7. , and since an enhancer is likely to be found in every 50 kb of cell DN A , nearly every translocation within a 50-kb radius of a proto -one gene should be activating. Thu s the probability that a given proto -one gene is activated per translocation would be 5 X 1 0 -3 (50 kb out of 106kb). T h e probability that one of the 20 known proto -one genes is activated would then be 10-3 per translocation.
Translocation frequencies per mitosis are not readily available. However in hamster cells they are estimated to occur with a probability of 10-6 per mitosis (Kraem er et al. 1986; Ray et al. 1986 ). In mice and humans even higher frequencies of 10-2 to 3 X 1 0 -1 have been reported in somatic cells studied in vitro (Terzi & Hawkins, 1975; Harnden et al. 1976; Martin et al. 1985) . T h e probability of a translocation per meiotic cell division in humans has been determined to be 10-3 to 10~4 based on chromosome abnormalities in live births (Hook, 1985) . Assuming one translocation in 104 mitoses, the probability that 1 out of the 20 known proto -one genes is activated per mitosis by translocation would then be about 10-7 .
(4) T h e probability that a proto-one gene would be activated from without by the promoter or enhancer of a retrovirus integrated nearby is even higher than those associated with the intrinsic mechanisms. Since retrovirus integration within 1 to 10 kb of a putative latent cancer gene is considered sufficient for activation ('RNA Tum or Viruses' 1985; Bishop, 1981; Klein, 1981; Bishop et al. 1982; Bishop, 1983; Varmus & Bishop, 1986) , and since retrovirus integration is not site-specific ('RNA Tum or Viruses' 1982 Viruses' , 1985 and since eukaryotes contain about 106 kb of D N A , a given proto-owc gene would be activated in at least 1 out of 106 infected cells (Duesberg, 1987 (Duesberg, , 1985 . T h e probability that any one of the 20 known proto -one genes would be activated would be 2 x lO-3 per infected cell.
T h e sum of these probabilities should reflect the spontaneous transformation frequency of cells per mitosis in vivo and in vitro. It would be between 10-5 and 10" 7. However, it should be at least 5 x 10-7 due to proto-ms mutations alone. T h e actual num ber may be 10 times lower or about 10-8 , depending on whether all or only some of these four putative mechanisms could activate a proto -one gene and depending on whether a given cell is susceptible to transformation by a given one gene or to a given retrovirus. Instead, spontaneous transformation per mitosis that leads to monoclonal tumours is only about 2 x l 0 -17 in vivo. Thu s the expected probability of spontaneous transformation due to activation of preexisting oncogenes differs at least by a factor of 109 from that observed in diploid cells in vivo.
Again it may be argued that spontaneous malignant transformation does indeed occur at this rate but that immunity eliminates nearly all transformants. However in this case athymic or nude mice should not exist (Sharkey & Fogh 1984) and diploid cells in culture would transform at the above rate.
THE HYPOTHESIS THAT ACTIVATED PROTO-ONC GENES REQUIRE UNKNOWN COMPLEMENTARY GENES FOR CARCINOGENESIS
In view of the consistent difficulties in demonstrating oncogenic function of protoonc genes, a further revision of the oncogene concept has recently been favoured. It proposes that 'activated' proto -one genes, like proto-ras or proto -myc, are not autonomous one genes like their viral derivatives, but are at least necessary for the kind of carcinogenesis that requires multiple cooperating oncogenes (Leder et al. 1983; Land et al. 1983; K lein & K lein, 1984; Balmain, 1985; Diamond et al. 1983; Varmus, 1984) . Thu s activated proto-one genes are proposed to be functionally different, yet structurally equivalent to viral one genes. According to this theory, activated proto -one genes would not be expected to register in transformation assays that detect single-hit carcinogens like viral one gnes (Duesberg, 1983 (Duesberg, , 1985 .
However, the hypothesis fails to provide even a speculative explanation for why activated proto -one genes are no longer to be considered functionally equivalent to viral one genes (Duesberg, 1985) . Clearly, until the postulated complementary cancer genes are identified, this hypothesis remains unproven (Duesberg, 1985) .
VIRAL ONC GENES AS SPECIFIC RECOMBINANTS BETWEEN TRUNCATED VIRAL AND CELLULAR GENES
On the basis of genetic and structural analyses of retroviral genes, viral one genes and proto -one genes and direct comparisons between them, we have found that viral one genes and proto-one genes differ both structurally and functionally. Therefore we have proposed that viral one genes are indeed new genes, that do not preexist in norm al cells, rather than being transduced cellular genes (D uesberg, 1983, 1985, 1979; W atson et al. 1983 ; Fig. 1) .
T h e original basis for this proposal was the definition of the transform ing gene of avian carcinom a virus MC29 (D uesberg et al. 1977 ) as a genetic hybrid, rather than a transduced cellular oncogene (M ellon et al. 1978) . It consists of 5' regulatory and coding elem ents (Agag) from an avian retrovirus linked to 3' coding elem ents from cellular proto-raj^c (Mellon et al. 1978 ; Fig. 1 ). Initially this becam e evident by com paring the structure and m ap order of MC29 w ith that of the three essential retrovirus genes, nam ely 5' gag-pol-env 3' (Wang et al. 1975; Wang, 1978 ; Fig. 1) .
Sequence com parison of the viral Agag-myc gene with the chicken proto-myc gene provided direct proof that only a truncated proto-«2jvr gene was present in MC29. Indeed a com plete 5' proto-w yc exon was missing from the viral Agag-mvc gene proto -one genes (Watson et al. 1983 ). T h is was apparently not an accident since the same 5' protomyc exon was also missing in the three other myc-containing avian carcinoma viruses MHZ Zhou et al. 1985) , C M II and OKIO (Duesberg, 1985; Hayflick et al. 1985) . Thu s a viral and a cellular gene functioned as progenitors or proto-one genes of each of the viral recombinant myc genes (Fig. 1) . More recently the four known viral ras genes were each also shown to lack a 5' proto-ras exon (Cichutek & Duesberg, 1986) (see above; Fig. 1 ).
Comparisons between the one genes of other retroviruses and the corresponding proto-one genes proved that all viral one are new genes that are spliced together from proto -one genes and retroviral genes (Duesberg, 1983 (Duesberg, , 1985 ; 'RNA Tum or Viruses' 1985; Fig. 1) . However, not all viral genes encode hybrid proteins. Based on the origin of their coding elements, the viral one genes can be divided into the four groups illustrated in Fig. 1: (1) Th ose with amino and carboxy terminal domains from retroviruses and central domains from proto -one genes. T h e one gene avian myeloblastosis virus (AM V) is the prototype ('RN A Tum or Viruses' 1985; Hayflick et al. 1985) .
( et al. 1980 ) and Abelson leukemia virus ('RNA Tum or Viruses' 1985) also have the generic Agag-'X. structure. Since three of the four groups of recombinant viral one genes also encode recombinant proteins, their specific transforming function can be directly related to their specific structure compared to that of proto -one gene products. T h e transform ing function of the recombinant one genes of group 3 which encode transforming proteins that are colinear with proteins encoded by proto -one genes cannot be explained in this fashion. However all viral one genes of this group each lack at least one proto-cwospecific 5' exon like the avian carcinoma viruses with myc genes (Duesberg, 1985; Watson et al. 1983; Kan et al. 1984; Zhou et al. 1985; Hayflick et al. 1985) or the murine sarcoma viruses with ras genes (Cichutek & Duesberg, 1986) . Conceivably elimination of transcribed or untranscribed suppressors or elimination of an upstream proto-ras cistron (Cichutek & Duesberg, 1986) or protom ye cistron (Bentley & Groudine, 1986) and recombination with viral promoters are the mechanisms that generate transforming function (Fig. 1) .
2) Th ose with amino terminal domains from viral genes and carboxy terminal domains from proto -one genes. T h e Agag-myc gene of M C29 is the original example (see above). T h e one genes of Fujinam i sarcoma virus (Lee
It follows that viral one genes and the corresponding proto -one genes are not isogenic. Viral one genes are hybrid genes that consist of truncated proto -one genes recombined with regulatory and frequently with coding elements from truncated retroviral genes. These consistent structural differences must be the reason why viral one genes inevitably transform and why proto-one genes are not transforming although they are present in all and are active in most normal cells (Duesberg, 1983 (Duesberg, , 1985 .
It may be argued that proto-one gene truncations reflect packaging restrictions of transducing retroviruses, rather than conditions to activate proto -one genes. Such restrictions would have to be mostly sequence-specific, as most retroviruses with one genes can accommodate more RN A , at least 10 kb as in R SV (Duesberg & Vogt, 1970) , than they actually contain, namely 3 to 8kb ('RN A Tum or Viruses' 1985) . However, there is no evidence that retroviruses discriminate more against certain transduced or artificially introduced sequences ('RNA Tum or Viruses' 1985) than against others, because retroviruses can accommodate very heterogeneous se quences, such as the 20 different transformation-specific sequences (Duesberg, 1983 (Duesberg, , 1985 'RN A Tum or Viruses' 1985; Duesberg, 1979 ). Yet all nonessential sequences of retroviruses are unstable (Duesberg, 1983 (Duesberg, , 1985 unless selected for a given function.
T h e experience that all known viral one genes are new genes that include only truncated proto-one genes is in itself an argument in favour of truncation as a condition for proto -one gene activation and against preexisting cellular oncogenes.
Clearly if cellular oncogenes preexist in normal cells, it would be much more likfely to find retroviruses with intact cellular oncogenes then retroviruses with new one genes put together from unrelated and truncated viral and cellular genes by illegitimate recombination. Moreover, the same exons were truncated from the same proto -one genes in completely independent viral transductions. Examples are selective trans ductions from proto-»zyc, the precursor of four avian carcinoma viruses (Duesberg, 1985; Watson et al. 1983; Kan et al. 1984) or proto-ras, the precursor of three murine sarcoma viruses (Cichutek & Duesberg, 1986) or proto-myb, the precursor of avian myeloblastosis and erythroblastosis viruses ('RN A Tum or Viruses' 1985; N unneia/. 1983) or proto-erb, the precursor of three avian sarcoma and erythroblastosis viruses ('R N A Tum or Viruses' 1985) or proto-/es, the precursor of three feline sarcoma viruses ('R N A Tum or Viruses' 1985) or p ro to n s , the precursor of three avian sarcoma viruses ('RN A Tum or Viruses' 1985) or proto-a6/, the precursor of Abelson murine leukemia and a feline sarcoma virus ('RNA Tum or Viruses' 1985) , or proto m os, the precursor of several Moloney sarcoma virus ('RNA Tum or Viruses' 1985; van der Hoorn et al. 1986 ) or proto-src, the precursor of R SV and two other avian sarcoma viruses (Ikawa et al. 1986 ). In the process of generating viral one genes from these proto -one genes, the same exons were in some cases selectively truncated at the same breakpoints, as for example the one genes of two sarcoma viruses generated from proto-^s (Pfaff et al. 1985) .
T h e existence of at least five retroviruses that have transduced proto -one sequences that had already been truncated and rearranged with other cellular genes prior to transduction, lends further independent support to this view. Examples are the one genes of R S V (Duesberg, 1983; 'RN A Tum or Viruses' 1985) of avian carcinoma virus M H 2 (Duesberg, 1985; Zhou et al. 1985; Hayflick et al. 1985) , of avian erythroblastosis and sarcoma virus AEV ('RN A Tum or Viruses' 1985) of avian erythro-and myeloblastosis virus E26 (Nunn et al. 1983 ) and of the feline sarcoma virus G R -F e S V ('RNA Tum or Viruses' 1982; Naharro et al. 1984) . Certainly the odds against transduction of rare rearranged proto -one genes instead of normal protoonc genes are overwhelming. Yet five out of the less than 50 known isolates of retroviruses with one genes ('RN A Tum or Viruses' 1985) contain previously rearranged proto -one sequences, most likely because truncation is necessary for transforming function. Indeed, it may be argued that these viruses have transduced these rearranged proto-owc genes from a preexisting tumour that was generated by these rearrangements. T hu s, the rearranged proto -one genes of these five oncogenic retroviruses may be 'transduced cellular oncogenes' after all.
A definitive assessment of why viral one genes transform and cellular proto -one genes don't, requires more than comparisons of prijnary structures and transforming tests with DN A s. It will be necessary to know what proto -one genes do and whether they encode proteins that function alone or as complexes with other proteins.
It is proposed then that proto-one genes that are transcriptionally activated or have undergone point mutations, but retain a germline structure, are not cellular cancer genes. T h e hypothesis that proto -one genes are latent cellular cancer genes that can be converted to active transforming genes by increasing dosage or function, is suggested to be an overinterpretation of sequence homology to structural and functional homology with viral one genes.
T h is proposal readily resolves the paradoxes posed by the hypothesis that protoonc genes are latent cellular cancer genes that can be activated by enhanced expression or point mutation. T h e proposal accounts for the frequent expression of proto -one genes in normal cells (Duesberg, 1985) . T h e proposal is also entirely consistent with the lack of transforming function of 'activated' proto -one genes from tumours. T h e fact that mutated proto-ras changes the morphology and enhances tumorigenicity of aneuploid and tumorigenic 3T 3 cells is an important observation, but not an exception to the experience that native proto -one genes from tumours analysed to date do not transform diploid cells. T h e proposal also provides a rationale for the chromosome abnormalities of tumour cells, as these appear to be microscopic evidence for cancer genes (see below), instead of the 'activated' proto -one genes identified to date.
THE HYBRID ONC GENES OF RETROVIRUSES AS MODELS OF CELLULAR CANCER GENES
T h e proposal that proto-one genes derive transforming function by truncation and recombination with retroviral genes predicts that illegitimate recombination among cellular genes could also generate transforming genes from proto -one genes. T h e generation of retroviral one genes from viral genes and proto -one genes could indeed be a model for this process. T h e view that cellular cancer genes are rare illegitimate recombinants of normal cellular genes is in accord with the fact that rearranged and abnormal chromosomes are the only consistent, transformation-specific markers of tumour cells (Wolman, 1983; Rowley, 1984; Trent, 1984; Duesberg, 1987; Levan, 1956) . Further the clonality of chromosome alterations, e.g., the marker chromo somes of tumours (Wolman, 1983; Rowley, 1984; T ren t, 1984; Duesberg, 1987; Levan, 1956) , indicates that tumours are initiated with and possibly caused by such abnormalities as originally proposed by T . Boveri in 1914.
As yet less than 50 isolates of retroviruses with one genes have been recorded in history (Duesberg, 1985; 'RN A Tum or Viruses' 1985) , although both potential parents of retroviral one genes are available in many animal or human cells because retroviruses are widespread in all vertebrates (Duesberg, 1987; 'RN A Tum or Viruses' 1985) . T h is extremely low birth rate of retroviruses with one genes must then reflect the low probability of generating de novo an oncogenic retrovirus from a proto-one gene and a retrovirus by truncating and recombining viral and cellular genes v ia illegitimate recombinations (Duesberg, 1983 (Duesberg, , 1985 (Duesberg, , 1979 . Clearly, two illegitimate recombinations are required (Fig. 1) . One to link a 3' truncated retrovirus with a 5' truncated proto-onc gene; the other to break and then splice the resulting hybrid one gene to the 3' part of the retroviral vector.
T h e first of these steps would already generate a 'cellular' cancer gene that ought to be sufficient for carcinogenesis. T h e birth of such a gene would be more probable than that of an oncogenic retrovirus that requires two illegitimate recombinations, but it would be harder to detect than a complete replicating retrovirus with an one gene. Nevertheless even this would be a rare event. Given that such a recombination would have to take place within the 8 to 9 kb of a retrovirus ( Fig. 1 ) integrated into the 106-kb genome of a eukaryotic cell and also within an estimated 1 to 2 kb of a proto -one gene ( Fig . 1 ) and assuming that translocation or rearrangement occurs with a probability of 10~4 (see above); the probability of such a recombination per mitosis would be 8 x 10~6 ■ 2 x 10~6 • 10-4 or 10-l s . T h at a second illegitimate recombination is required to generate a retrovirus with an one gene would explain why the occurrence of these viruses is much less frequent than spontaneous transformation. T h is probability may, nevertheless, be higher than the square of 10-13, since the two events may be linked and since multiple integrated and unintegrated proviruses exist in most infected cells.
T h e probability that rearrangements would generate cancer genes from normal cellular genes would also be very low, since most rearrangements would inactivate genes. T h e above estimates for the probability of spontaneous transformation of 2 x 1CT17 per mitosis and of translocation of 10~4, which would be a minimal estimate for rearrangements, suggest that 1013 translocations or rearrangements are needed to generate a transforming gene that causes a monoclonal tumour. T h is could either be a single autonomous transforming gene that is like a viral one gene, or it could be a series of mutually dependent transforming genes that would each arise with a higher probability than an autonomous one gene. T h e facts that multiple chromosome alterations are typically seen in tumours (Wolman, 1983; Rowley, 1984; T ren t, 1984; Levan, 1956 ) and that as yet no DN As have been isolated from tumours that transform diploid cells with single-hit kinetics, suggest that most cellular cancer genes are indeed not autonomous carcinogens like viral one genes. It is consistent with this experience that most cellular genes are also not converted to autonomous cancer genes by retroviral transduction and truncation. Only about 20 cellular genes, the proto-one genes, have been converted to autonomous viral one genes, although viral transduction is a random event that does not benefit from sequence homology between retroviruses and cells (Duesberg, 1983 (Duesberg, , 1985 (Duesberg, , 1979 ).
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